AI-powered search

Derms and Conditions Podcast Episode 2:

Clinical Pearls in Dermatology in More than a New York Minute with David Cohen, MD (Part 2)

Release Date: April 15, 2021

In Part 2 of our conversation, James Del Rosso, DO and David Cohen, MD discuss the use of currently available and new systemic therapies for Atopic Dermatitis and Psoriasis. All that and a lot more in this episode of Derms and Conditions.

David Cohen, MD
Vice Chair for Clinical Affairs and the Charles C. And Dorothea E. Harris Professor of Dermatology
NYU Langone Health
New York, NY

James Q. Del Rosso, DO
Adjunct Clinical Professor (Dermatology)
Touro University College of Osteopathic Medicine
Henderson, NV

Financial Disclosures:

James Del Rosso, DO:

Abbvie, Aclaris, Almirall, Amgen, Arcutis, Bausch Health (Ortho Dermatology), BioFrontera, BioPharmX, Bristol-Myers-Squibb, Cassiopea, Dermata, Dermavant, Encore, EPI Health, Evommune, Ferndale, Galderma, Incyte, JEM Health, Leo Pharma, La Roche Posay, Lilly (Dermira), MC2, Novan, Pfizer, Regeneron, Sanofi-Genzyme, SolGel, Sonoma (IntraDerm), Sun Pharma, Trevi, UCB, Verrica, Vyne (Foamix; Menlo)

Aclaris, Almirall, Amgen, Arcutis, Bausch Health (Ortho Dermatology), EPI Health, Ferndale, Galderma, Genentech, JEM Health, Leo Pharma, La Roche Posay, Lilly (Dermira), Pfizer, Regeneron, Sanofi-Genzyme, Sun Pharma, UCB, Verrica, Vyne (Foamix; Menlo)

Aclaris, Almirall, Amgen, Anaptys Bio, Arcutis, Athenex, Bausch Health (Ortho Dermatology), BioPharmX, Biorasi, Botanix, Brickell, Cara Therapeutics, Cassiopea, Dermavant, EPI Health, Ferndale, Galderma, Incyte, Leo Pharma, Lilly (Dermira), Novan, Pfizer, Ralexar, Regeneron, SolGel, Sun Pharma, UCB, Verrica, Vyne (Foamix; Menlo)

David Cohen, MD:

Consultant and Honorarium: 
  • Ferndale Laboratories, 
  • Asana
  • Medimetriks [past]
  • Leo
  • UCB
  • Novartis
  • Dermavant
  • FSJ
  • FIDE. (FIDE receives industry sponsorship from AbbVie, Almirall, Amgen, Arcutis, Bausch and Lomb, Bristol-Myers Squibb, Celgene Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Regeneron, Sun Pharma, UCB, Valeant)
  • Cosmetic Ingredient Review (CIR)
Stock or stock options:  Dermira [past], Medimetriks [past], Brickell Biotech [past], Kadmon, Evommune, Timber
Board of Directors:  Kadmon, Timber, Evommune, Dermira-[Past]

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us


Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved